Latest Breaking News On - Alexandra herrmann - Page 1 : comparemela.com

Immunic (IMUX) Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium

Immunic (IMUX) Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDaniel vittRobertj foxAlexandra herrmannResearch in multiple sclerosisNeurological instituteMellen centerImmunic incAmericas committee for treatmentAmericas committeeMultiple sclerosisPalm beachChief executive officerVidofludimus calciumSerum neurofilamentStaff neurologist

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEdna kaplanPaula schwartzJessica breuDaniel vittRobertj foxAlexandra herrmannMellen centerExchange commissionNeurological instituteResearch in multiple sclerosisAmericas committee for treatmentImmunic incAmericas committeeMultiple sclerosisPalm beach

EQS-News: Immunic, Inc : Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024

EQS-News: Immunic, Inc : Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesEdna kaplanRobertj foxJessica breuAlexandra herrmannPaula schwartzDaniel vittMellen centerAmericas committee for treatmentResearch in multiple sclerosisNeurological instituteImmunic incExchange commissionDistribution servicesRx communications groupPresents data from phase

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesAlexandra herrmannDaniel vittPaula schwartzEdna kaplanRobertj foxJessica breuNeurological instituteImmunic incAmericas committee for treatmentExchange commissionMellen centerResearch in multiple sclerosisPresents data from phaseVidofludimus calciumAmericas committee

Immunic to Participate in Investor and Scientific Conferences in February

NEW YORK, Feb. 1, 2024 /PRNewswire/ Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and.

United statesNoord hollandPaula schwartzBiocapital europeJessica breuEdna kaplanAlexandra herrmannDaniel vittRobertj foxExchange commissionRx communications groupNeurological instituteMellen centerImmunic incChief executive officerVice president investor relations